Cancer Research Technology (CRT), charity Cancer Research UK’s subsidiary to commercialise academic research into oncology treatments, has set up a £50m ($80m) venture fund.
CRT and the European Investment Fund (EIF), a state-backed organisation that is the largest investor – called limited partner – in European venture capital funds, will equally split the commitments for the £50m fund, called CRT Pioneer fund.
The money will be committed in two tranches of £25m – now and in two years’ time…
A new $35m fund will be managed by external venture studio High Alpha Innovation and will work with the university on creating new startups.
Basel has quietly built a life sciences ecosystem that’s becoming hard to ignore.
From a chest-worn device to help with Parkinson's symptoms to stress measuring socks — here are the spinouts providing support for senior citizens.
Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.
